Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis
Introduction The introduction of multiparametric MRI (mpMRI) has enabled enhanced risk stratification for men at risk of prostate cancer, through accurate prebiopsy identification of clinically significant disease. However, approximately 10%–20% of significant prostate cancer may be missed on mpMRI....
Saved in:
| Main Authors: | Clare Allen, Alex Freeman, Mark Emberton, Daniel Kelly, Joseph M Norris, Benjamin S Simpson, Marina A Parry, Rhys Ball, Alex Kirkham, Veeru Kasivisvanathan, Hayley C Whitaker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/1/e034611.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis
by: Yi Zhao, et al.
Published: (2023-08-01) -
Automatic sequence identification in multicentric prostate multiparametric MRI datasets for clinical machine-learning
by: José Guilherme de Almeida, et al.
Published: (2025-03-01) -
Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI
by: Antonia M. Pausch, et al.
Published: (2025-06-01) -
Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01) -
Micro-Ultrasound in the Detection of Clinically Significant Prostate Cancer: A Comprehensive Review and Comparison with Multiparametric MRI
by: Julien DuBois, et al.
Published: (2025-07-01)